Results 151 to 160 of about 30,706 (198)

Domains of Structured Oral Anticancer Medication Programs: A Scoping Review

Oncology Nursing Forum, 2022
An interprofessional approach is necessary to support the multifactorial process of patient adherence to oral anticancer medications (OAMs). This scoping review aims to identify structured OAM programs in published literature, identify components within studies, and propose a framework for institutions developing or maintaining OAM programs.Embase ...
Kapeena, Sivakumaran, Pamela K, Ginex, Haya, Waseem, Sarah M, Belcher, Sarah, Lagler-Clark, Kristine B, LeFebvre, Nicole, Palmer, Tejanth, Pasumarthi, Rebecca L, Morgan   +8 more
openaire   +2 more sources

Impact of medically integrated pharmacies on oral anticancer medication prescription abandonment.

JCO Oncology Practice, 2023
66 Background: Due to the high cost of oral anticancer medications, financial toxicity may limit patient access to treatment. Abandonment occurs when a patient does not fill a prescription. Higher out of pocket costs have been associated with higher rates of prescription abandonment of treatment across cancers with national abandonment rates ...
Gury K. Doshi, Lalan S. Wilfong, Neal Dave, Wendy Hemmen   +3 more
openaire   +1 more source

Improved oral anticancer medication (OAM) adherence/toxicity assessment documentation.

JCO Oncology Practice, 2023
409 Background: Based on national OAM guidelines and to improve patient safety, most OAM programs monitor toxicity/adherence within 10-14 days following OAM initiation. At our institution, only 50% of toxicity/adherence documentation tasks were completed by day 10 of cycle 1 after initiating OAM.
Lisa Holle, Andrea Moran, Margaret Savage, Michael Kenneth Keng   +3 more
openaire   +1 more source

Medication adherence to oral anticancer drugs: systematic review

Expert Review of Anticancer Therapy, 2016
Many studies have demonstrated that non-adherence to oral anticancer drugs (OACDs) has challenged treatment efficacy. Otherwise, few validated tools exist to measure patients' adherence to medication regimen in clinical practice. To synthesize previous studies on adherence by cancer patients taking OACDs, especially in targeted therapy, a systematic ...
Wen-Chuan, Huang, Chung-Yu, Chen, Shun-Jin, Lin, Chao-Sung, Chang   +3 more
openaire   +2 more sources

Potential Obstacles in the Acquisition of Oral Anticancer Medications

Journal of Oncology Practice, 2017
Purpose: To determine the amount of time elapsed between prescriber order and patient receiving oral anticancer medication. Patients and Methods: Adult patients with a diagnosis of cancer were prospectively identified in three outpatient oncology clinics when oral anticancer agents were prescribed during a 4-month observation period.
Jennifer L, Niccolai, Danielle L, Roman, Justin M, Julius, Rachelle W, Nadour   +3 more
openaire   +2 more sources

Human capital costs of obtaining oral anticancer medications.

Journal of Clinical Oncology, 2016
6506Background: Oral anticancer medications (OAMs) are commonly prescribed for various cancers. Initiating OAMs can involve extensive effort from clinic staff, including obtaining prior authorizati...
Yu-Ning Wong, Caitlin Meeker, Jamie Doyle, Elizabeth Handorf, Marijo Bilusic, Elizabeth R. Plimack, Daniel M. Geynisman   +6 more
openaire   +1 more source

Oral anticancer medication: Does the patient understand?

Journal of Clinical Oncology, 2013
219 Background: Oral anti-cancer medication (OAM) prescribing is increasing. Safety and adherence issues surrounding OAM are causing a shift in the traditional roles and responsibilities of oncologists, nurses and pharmacists. This study aims to investigate patients’ perception of education and safety surrounding OAM use.
Donna M. Graham, Alan O'Shea, Jeffri R. M. Ismail, Richard Martin Bambury, Margaret O'Keefe, Catherine Drake, Eugene J. Moylan, Derek Gerard Power, Seamus O'Reilly   +8 more
openaire   +1 more source

Impact of Oral Anticancer Medication From a Family Caregiver Perspective

Oncology Nursing Forum, 2018
To describe how family caregivers of patients receiving oral anticancer medication (OAM) may affect family caregivers' lives and determine what support caregivers need to manage OAM in the home successfully.Family caregivers of individuals with cancer prescribed OAM recruited from oncology clinics in the Midwest region of the United States.Focus group ...
Victoria K, Marshall, Eric A, Vachon, Barbara A, Given, Rebecca H, Lehto   +3 more
openaire   +2 more sources

A review of economic impact of targeted oral anticancer medications

Expert Review of Pharmacoeconomics & Outcomes Research, 2013
There has been a rapid increase in the use of targeted oral anticancer medications (OAMs) in the past decade. As OAMs are often expensive, economic consideration play a significant role in the decision to prescribe, receive or cover them. This paper performs a systematic review of costs or budgetary impact of targeted OAMs to better understand their ...
Chan, Shen, Chun-Ru, Chien, Daniel M, Geynisman, Fabrice, Smieliauskas, Ya-Chen T, Shih   +4 more
openaire   +2 more sources

Interventions to Support Adherence to Oral Anticancer Medications: Systematic Review and Meta-Analysis

Oncology Nursing Forum, 2022
This systematic review compared the efficacy of interventions to usual care on adherence to oral anticancer regimens.Embase®, PubMed®, and CINAHL® were searched for eligible comparative studies published between January 2000 and May 2021. Outcomes of interest included adherence, cancer-related morbidity, quality of life, patient satisfaction, and other
Haya, Waseem, Pamela K, Ginex, Kapeena, Sivakumaran, Gina M, DeGennaro, Sarah, Lagler-Clark, Kristine B, LeFebvre, Nicole, Palmer, Tejanth, Pasumarthi, Paula, Rieger, Kelli, Thoele, Rebecca L, Morgan   +10 more
openaire   +2 more sources